A study of AMG 416 in the treatment of secondary hyperparathyroidism in chronic kidney disease To characterize the long-term safety and tolerability of AMG 416 in the treatment of SHPT in subjects with chronic kidney disease on hemodialysis.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A study of AMG 416 in the treatment of secondary hyperparathyroidism in chronic kidney disease To evaluate the efficacy and safety of AMG 416 in the treatment of secondary hyperparathyroidism (SHPT) in subjects with chronic kidney disease (CKD) on hemodialysis. Primary: To evaluate the effi...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A study of AMG 416 in the treatment of secondary hyperparathyroidism in chronic kidney disease To characterize the long-term safety and tolerability of AMG 416 in the treatment of SHPT in subjects with CKD on hemodialysis.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Compare therapeutic efficacy and safey of AMG 416 and cinacalcet HCl in hemodialysis subjects with secondary hyperparathyroidism Demonstrate that treatment with AMG 416 is not inferior to treatment with cinacalcet for lowering plasma intact parathyroid hormone (PTH) levels by > 30% from baseline among subjects with chronic kidn...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune